Surviving sepsis campaign - Outcome of severe sepsis can be improved by revising procedural standards

Acta Anaesthesiologica Scandinavica

Volumn 49, Issue 5, 2005, Pages 597-598

  Ruokonen, Esko ^a   Pettila, V ^b  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; DISEASE SEVERITY; EDITORIAL; HEART INFARCTION; HUMAN; INTENSIVE CARE; PRIORITY JOURNAL; SEPSIS; SEPTIC SHOCK; STANDARD; SURVIVAL; TISSUE OXYGENATION; TREATMENT OUTCOME;

HUMANS; INTENSIVE CARE; PROGNOSIS; SEPSIS; SHOCK, SEPTIC; TREATMENT OUTCOME;

EID: 17844394959     PISSN: 00015172     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-6576.2005.00716.x     Document Type: Editorial

References (9)

1. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States, analysis of incidence, outcome and associated costs of care. Crit Care Med 2001; 29 (7): 1472-4.
2. Rivers E, Nguyen B, Havstad S et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001; 345: 1368-77.
3. Bernard G, Vincent JL, Laterre PF et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001; 344: 699-709.
4. Angus, Derek CMB, ChB, MPH. Laterre Pierre-Francois MD, Helterbrand et al. The effect of drotrecogin alfa (activated) on long-term survival after severe sepsis. Crit Care Med 2004; 32 (11): 2199-206.
5. The Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal Volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000; 342: 1301-8.
6. Van den Berghe G, Wouters P, Weekers F et al. Intensive insulin therapy in the critically ill patients. N Engl J Med 2001; 345: 1359-67.
7. Lopez A, Lorente JA, Steingrub J et al. Multiple center, randomized, placebo-controlled, double-blinded study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock. Crit Care Med 2004; 32: 21-30.
8. Annane D, Sebille V, Charpentier C et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002; 288: 862-71.
9. Hamrahan AH, Oseni TS, Arafah BM. Measurements of free cortisol in critically ill patients. N Engl J Med 2004; 350: 1629-38.